368 related articles for article (PubMed ID: 24946270)
1. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
Anitha A; Deepa N; Chennazhi KP; Lakshmanan VK; Jayakumar R
Biochim Biophys Acta; 2014 Sep; 1840(9):2730-43. PubMed ID: 24946270
[TBL] [Abstract][Full Text] [Related]
2. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
[TBL] [Abstract][Full Text] [Related]
3. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
Song Q; Jia J; Niu X; Zheng C; Zhao H; Sun L; Zhang H; Wang L; Zhang Z; Zhang Y
Nanoscale; 2019 Aug; 11(34):15958-15970. PubMed ID: 31418432
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.
Ortiz R; Prados J; Melguizo C; Arias JL; Ruiz MA; Alvarez PJ; Caba O; Luque R; Segura A; Aránega A
Int J Nanomedicine; 2012; 7():95-107. PubMed ID: 22275826
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.
Alkhader E; Roberts CJ; Rosli R; Yuen KH; Seow EK; Lee YZ; Billa N
J Biomater Sci Polym Ed; 2018 Dec; 29(18):2281-2298. PubMed ID: 30376409
[TBL] [Abstract][Full Text] [Related]
6. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
7. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A
Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930
[TBL] [Abstract][Full Text] [Related]
8. Formulation of Quaternized Aminated Chitosan Nanoparticles for Efficient Encapsulation and Slow Release of Curcumin.
Omer AM; Ziora ZM; Tamer TM; Khalifa RE; Hassan MA; Mohy-Eldin MS; Blaskovich MAT
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467056
[TBL] [Abstract][Full Text] [Related]
9. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer.
Tang Q; Wang Y; Huang R; You Q; Wang G; Chen Y; Jiang Z; Liu Z; Yu L; Muhammad S; Wang X
PLoS One; 2014; 9(6):e98455. PubMed ID: 24896096
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.
Cheng M; Han J; Li Q; He B; Zha B; Wu J; Zhou R; Ye T; Wang W; Xu H; Hou Y
J Biomed Mater Res B Appl Biomater; 2012 Nov; 100(8):2035-43. PubMed ID: 22865703
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer.
Badran MM; Mady MM; Ghannam MM; Shakeel F
Int J Biol Macromol; 2017 Feb; 95():643-649. PubMed ID: 27908720
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery.
Samprasit W; Opanasopit P; Chamsai B
Pharm Dev Technol; 2021 Mar; 26(3):362-372. PubMed ID: 33423571
[TBL] [Abstract][Full Text] [Related]
13. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.
Sharma A; Kaur A; Jain UK; Chandra R; Madan J
Colloids Surf B Biointerfaces; 2017 Jul; 155():200-208. PubMed ID: 28431329
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.
Yu X; Hou J; Shi Y; Su C; Zhao L
Int J Nanomedicine; 2016; 11():6035-6046. PubMed ID: 27881917
[TBL] [Abstract][Full Text] [Related]
16. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
Li S; Wang A; Jiang W; Guan Z
BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
[TBL] [Abstract][Full Text] [Related]
18. In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells.
Zhao H; Liu Q; Wang S; Dai F; Cheng X; Cheng X; Chen W; Zhang M; Chen D
Cancer Med; 2017 Jul; 6(7):1698-1706. PubMed ID: 28573788
[TBL] [Abstract][Full Text] [Related]
19. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
Ganguly K; Kulkarni AR; Aminabhavi TM
Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
